Literature DB >> 2909555

Influence of antiopioids on luteinizing hormone pulsatility in aging men.

A Vermeulen1, J P Deslypere, J M Kaufman.   

Abstract

To investigate whether changes in opioid tone play a role in the age-associated changes in LH release in men, the influence of an antiopioid, naltrexone, on plasma LH levels and LH pulses was studied in a group of young and elderly normal men. The young and elderly men had similar basal LH pulse frequencies, but the frequency of high amplitude (greater than 2 IU/L) LH pulses, mean LH pulse amplitude, maximal LH pulse amplitude and pulse area, were lower in the elderly men. Naltrexone administration (40 mg at 0630 and 2200 h the day before blood sampling and at 0630 h, 30 min before starting frequent blood sampling at 10-min intervals for 12 h) to young men (n = 8) induced a significant increase in individual mean baseline plasma LH levels, LH pulse frequency, and the sum of LH pulse amplitudes. In elderly men (n = 11) only a borderline significant increase in baseline plasma LH levels occurred, and neither LH pulse frequency nor the sum of the amplitudes of LH pulses increased. We suggest that in elderly men either opioid tone or the response of the gonadotrophs to endogenous LHRH is decreased.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2909555     DOI: 10.1210/jcem-68-1-68

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  10 in total

1.  Older males secrete luteinizing hormone and testosterone more irregularly, and jointly more asynchronously, than younger males.

Authors:  S M Pincus; T Mulligan; A Iranmanesh; S Gheorghiu; M Godschalk; J D Veldhuis
Journal:  Proc Natl Acad Sci U S A       Date:  1996-11-26       Impact factor: 11.205

2.  Age in men does not determine gonadotropin-releasing hormone's dose-dependent stimulation of luteinizing hormone secretion under an exogenous testosterone clamp.

Authors:  Ali Iranmanesh; Thomas Mulligan; Johannes D Veldhuis
Journal:  J Clin Endocrinol Metab       Date:  2010-03-31       Impact factor: 5.958

Review 3.  Effect of opioid antagonists on sex hormone secretion.

Authors:  H Tenhola; D Sinclair; H Alho; T Lahti
Journal:  J Endocrinol Invest       Date:  2011-12-15       Impact factor: 4.256

Review 4.  Risks versus benefits of testosterone therapy in elderly men.

Authors:  S Basaria; A S Dobs
Journal:  Drugs Aging       Date:  1999-08       Impact factor: 3.923

Review 5.  Age-related changes in male gonadal function. Implications for therapy.

Authors:  D Maas; A Jochen; B Lalande
Journal:  Drugs Aging       Date:  1997-07       Impact factor: 3.923

6.  Fundamental aspects of hypogonadism in the aging male.

Authors:  Alvin M Matsumoto
Journal:  Rev Urol       Date:  2003

Review 7.  The aging male hypothalamic-pituitary-gonadal axis: pulsatility and feedback.

Authors:  Johannes D Veldhuis; Daniel M Keenan; Peter Y Liu; Ali Iranmanesh; Paul Y Takahashi; Ajay X Nehra
Journal:  Mol Cell Endocrinol       Date:  2008-09-17       Impact factor: 4.102

Review 8.  Impotence in elderly men.

Authors:  J E Morley; F E Kaiser
Journal:  Drugs Aging       Date:  1992 Jul-Aug       Impact factor: 3.923

Review 9.  Trophic factors in aging. Should older people receive hormonal replacement therapy?

Authors:  D T Villareal; J E Morley
Journal:  Drugs Aging       Date:  1994-06       Impact factor: 3.923

Review 10.  Testosterone deficiency in non-cancer opioid-treated patients.

Authors:  F Coluzzi; D Billeci; M Maggi; G Corona
Journal:  J Endocrinol Invest       Date:  2018-10-20       Impact factor: 4.256

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.